Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of TPI 287 in Patients With Metastatic Prostate Cancer Who Have Progressive Neoplastic Disease Following Treatment With One Prior Taxane Regimen

NCT00479635 is registered in ClinicalTrials.gov with Cortice Biosciences, Inc. as lead sponsor.

NCT NCT00479635
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00479635 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of TPI 287 in Patients With Metastatic Prostate Cancer Who Have Progressive Neoplastic Disease Following Treatment With One Prior Taxane Regimen
Lead sponsor
Cortice Biosciences, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2007
Completion date
August 31, 2008
Enrollment
26 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer